Unifocal Granuloma of Femur due to Langerhans' Cell Histiocytosis: A Case Report and Review of the Literature by Singh, Harpreet et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 686031, 3 pages
doi:10.1155/2010/686031
Case Report
UnifocalGranulomaof Femur due to Langerhans’Cell
Histiocytosis: A Case Report and Reviewof the Literature
Harpreet Singh,1 SatnamKaur,2 P. Yuvarajan,1 NishantJain,1 andLalitMaini1
1Department of Orthopaedics, Maulana Azad Medical College and associated Lok Nayak Hospital, Delhi 110002, India
2Department of Pediatrics, Lady Hardinge Medical College and associated Kalawati Saran Children’s Hospital,
New Delhi 110001, India
Correspondence should be addressed to Harpreet Singh, harry d2004@yahoo.com
Received 4 May 2010; Accepted 16 July 2010
Academic Editor: Carol Lally Shields
Copyright © 2010 Harpreet Singh et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The radiological diagnosis of osteolytic lesions of the long bones in pediatric population constitutes a challenge when the case
history and clinical data are uncharacteristic. We believe that the description of few clinically and histologically proven cases
to verify the existence of radiological signs useful for diagnosis may be of interest. Here, we describe a case of Langerhans’ cell
histiocytosis (LCH) presenting as unifocal eosinophilic granuloma of femur along with a brief review of the literature.
1.Introduction
Langerhans’ cell histiocytosis (LCH) is a rare pediatric
disease. The disease manifestations are varied and protean.
A high index of suspicion is required for making an early
diagnosis and initiating appropriate treatment, especially
important for multisystem disease. Here, we report a case
of LCH presenting with unifocal eosinophilic granuloma of
femur and typical skin manifestations with probable central
nervous system involvement.
2.CaseReport
An eight-year-old girl presented to us with complaints of
diﬀuse swelling of the right thigh and skin rash. Her parents
denied history of fever, swelling anywhere else, any systemic
complaints, bleeding from any site, or trauma. On local
examination,herrightthighwasdiﬀuselyswollenandtender
to touch. There were no signs of inﬂammation. No abnormal
mobility was found in the underlying femur. General
physical examination revealed scaly, erythematous, brown
to red papular lesions over the scalp, abdomen, inguinal
region, and palms (Figure 1). There was no pallor, icterus,
lymphadenopathy, clubbing, edema, or swelling anywhere
else. Rest of the general as well as systemic examination was
unremarkable. X-ray of the limb showed a well-deﬁned lytic
expansile lesion in the diaphysis of femur with surrounding
periosteal reaction (Figure 1). Rest of her investigations
including complete hemogram, liver function tests, coag-
ulation proﬁle, skeletal survey, and chest radiograph were
unyielding. Patient was treated conservatively by us with
a functional brace while being investigated for the cause.
The skin lesion biopsy revealed inﬂammatory lesion with
numerous uni-, bi-, and multinucleated histiocytes in the
background of numerous eosinophils and lymphocytes. The
patient was subjected to bone biopsy which showed similar
ﬁndings consistent with Langerhans’ cell histiocytosis. The
follow-up radiograph of femur at two weeks showed signs of
healing of the lesion. However, two weeks after presentation,
the child developed alteration of sensorium and started
having recurrent seizures associated with symptoms of
raised intracranial pressure. There was no associated fever,
signs of meningeal irritation, or focal neurological deﬁcit.
She succumbed to her illness within 72 hours. MRI head
could not be done due to very sick general condition
of child and CSF study was not done because of raised
intracranial pressure and suspected space occupying lesion.
P o s t m o r t e ml u m b a rp u n c t u r ea sw e l la sa u t o p s yw a sr e f u s e d
by parents which would have thrown light on underlying
CNS pathology.2 Case Reports in Medicine
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Figure 1: Picture showing the clinico-radiological presentation of
the case.
3. Discussion
Childhood histiocytosis constitutes an diverse group of
disorders characterized by an intense proliferation of cells
of monocyte-macrophage system of bone marrow origin.
The writing group of the Histiocyte Society divided histi-
ocytosis syndromes in children into three classes: class I is
Langerhans’ cell histiocytosis; class II (non-LC histiocytosis)
includes the familial and virus-associated haemophagocytic
syndromes, sinus histiocytosis with massive lymphadenopa-
thy (Rosai-Dorfman), juvenile xanthogranuloma, and retic-
ulohistiocytoma; class III consists of the malignant histi-
ocytic diseases [1]. More recently, a revised classiﬁcation
schema included division into (1) dendritic cell disorders:
Langerhans cell histiocytosis (LCH), secondary dendritic
cell processes, juvenile xanthogranuloma, and solitary his-
tiocytoma with a dendritic phenotype; (2) macrophage-
related disorders: primary and secondary hemophagocytic
syndrome, Rosai-Dorfman disease, and solitary histiocy-
toma with a macrophage phenotype; (3) malignant histio-
cytic disorders: monocyte related leukemia, extramedullary
monocytic tumor, and dendritic cell or macrophage-related
histiocytic sarcoma [2].
Langerhans’ cell histiocytosis (LCH) occurs with an
estimated incidence of about two to ﬁve cases per million
yearly [3]. The three clinical variants of LCH include
eosinophilic granuloma (EG), Hand-Schuller-Christian dis-
ease, and Letterer-Siwe disease. The condition is charac-
terized by abnormal proliferation and dissemination of
histiocytes, which are identical to the normal dendritic cells,
ﬁrst noted by Langerhans. The cause and pathogenesis of
Langerhans’ cell histiocytosis remain unclear, but the disease
is believed to result from a disorder of immune regulation
[4–6].
LCH has an extremely variable presentation. The skele-
ton is involved in 80% of patients and may be the only
aﬀected site especially in children >5y e a ro fa g e[ 7]. EG
has been reported to aﬀect all the bones except those of the
handandfeet[8–10].Theskull,femur,ribs,vertebrae,pelvis,
long bones, and mandible are involved more commonly.
Polyostotic-monostotic ratio cited in the literature averages
1:3(range1:2to1:6)[11–15]. Painful swelling is the most
common initial sign. Proptosis from the lesion of orbital
wall may be present. When mastoid process is involved, the
ﬁndings can mimic mastoiditis. Extension to the middle ear
can cause destruction of ossicles and deafness. EG of jaw
bone is often associated with contiguous soft tissue swelling,
“ﬂoating teeth,” gingival swelling, fracture, or pain. In spine,
the lytic lesion can result in compression and collapse of
vertebral body, causing vertebra plana.
Cutaneous lesions, which may be present in association
with bony involvement, frequently manifest as scaly, ery-
thematous, seborrhea-like brown to red papules, especially
pronounced in post auricular, axillary, inguinal, perineal
areas, and over the scalp. The lesions may spread to involve
the back, palms, and soles. About 50% of patients exhibit
skin involvement at some time during the course of disease
[7]. Other manifestations include localized/disseminated
lymphadenopathy (33%), hepatosplenomegaly (20%), vary-
ing degree of hepatic malfunction, pulmonary and CNS
involvement.
Conventional analogical radiograms proved to be very
suitable investigation, although use of digital technique has
improved perception of details. In long bone, the lesion
appears as an irregular lytic area in the medulla, usually
with endosteal erosion. Marked cortical destruction may be
evident and there may be an onion skin appearance due to
periosteal reaction in diaphyseal lesions. Marginal sclerosis
indicates that the lesion is healing. Long bone lesions are
considered to be healed when the trabecular pattern has
returned to normal or when lytic area had been totally
replaced by a localized area of sclerosis. Flat bone lesions
appear as irregular lytic areas. Either complete resolution
may occur upon healing or lytic area may remain, though
with a well-deﬁned sclerotic margin [13, 15, 16]. In addition
to radiography, other useful imaging techniques include
skeletal scintigraphy (to identify any additional lesion, if
any), Color Doppler (to rule out aneurysm), and magnetic
resonance (to conﬁrm a cystic lesion as ﬂuid content is
indicated by marked signal hypo intensity in T1 spin echo
sequence and hyperintensity in T2 spin echo sequence) [17–
19]. CT scan enables correct localization and can be used to
plan the biopsy and treatment.
Diagnosis of LCH is conﬁrmed by histological exam-
ination. The usual histopathological appearance is collec-
tions of eosinophilic polymorphs, always accompanied by
histiocytes, and with varying proportion of lymphocytes,
granulocytes, monocytes and plasma cells. Multinuclear
giant cells of osteoclast type are occasionally present, but
never in large numbers. Fibroblastic diﬀerentiation may be
observed and is considered as evidence of healing. The
diagnosis of Langerhans’ cell histiocytosis is regarded as
presumptive when the typical morphological characteristics
of Langerhans’ cells are seen with light microscopy and as
designated when additional stains (e.g., protein S-100) are
positive. Diagnosis is conﬁrmed if stains for CD1a antigen
are positive or when intracytoplasmic organelles (Birbeck
granules) are seen with electron microscopy [4, 20, 21].Case Reports in Medicine 3
Organ dysfunction, rather than the extent of the lesions,
is the most important prognostic feature and the aim of
treatment is to correct such dysfunction as well as to
limit the spread of the disease [4, 5]. The clinical course
of single-system disease (usually bone, lymph node or,
skin) is usually benign with a high chance of spontaneous
remission. Therefore, treatment should be minimal. In
contrast, multisystem disease should be treated with multi-
agent chemotherapy. Early diagnosis improves the response
rate. Experimental therapies (indicated only for unre-
sponsive disease) include immunosuppressive therapy with
cyclosporine/antithymocyte globulin and certain new agents
and modalities, such as imatinib, 2-chlorodeoxyadenosine,
and stem cell transplantation.
Currently accepted treatment modalities for EG include
surgical curettage and ﬁlling the cavity with cancellous bone
and intralesional steroids (for lesions in accessible areas) [9,
19, 21]. Also it responds well to low dose radiotherapy which
isusuallyreservedforinaccessibleareas.Moststudiessuggest
that the dose should not be greater than 10Gy [9, 22].
To conclude, LCH is a rare disease presenting in pediatric
population.Nevertheless,itshouldbeconsideredindiﬀeren-
tial diagnosis in children presenting with unifocal/multifocal
osteolytic lesion especially in the presence of characteristic
skin lesions. Consideration of important clinical clues may
avoid delay in diagnosis which is an important predictor
of response to treatment especially in multisystem disease.
Characteristic imaging features described in this study may
raise suspicion of LCH but are not suﬃcient for diagnosis.
Appropriate histopathological studies are required to estab-
lish a diagnosis of LCH. While no standard of care exists for
the treatment of LCH, management should be tailored to
theindividualpatientbaseduponextentofdisease,anatomic
location, and radiographic extent of involvement.
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